Post-marketing Surveillance of Ventilat® in Long-term Therapy in Chronic Obstructive Pulmonary Disease
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to obtain further information on the tolerability and efficacy of Ventilat® metered
dose inhaler in long-term treatment of Chronic Obstructive Pulmonary Disease under conditions
of daily practice